✦ LIBER ✦

Low frequency of hCDC4 mutations in human primary ovarian cancer

✍ Scribed by A. Sgambato; V. Masciullo; M. Di Salvatore; P. Valdivieso; G. Bianchino; A. Zupa; G. Improta; C. Graziani; A. Rettino; R.A. Cifarelli; A. Cittadini; G. Scambia

Book ID: 113960987
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 173 KB
Volume: 105
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2007.01.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infrequent mutations of Archipelago (hAG

Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer

✍ Eunice L. Kwak; Kenneth H. Moberg; Doke C.R. Wahrer; Jennifer E. Quinn; Paula M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 841 KB

Loh and mutation analysis of CDKN2 in pr

Loh and mutation analysis of CDKN2 in primary human ovarian cancers

✍ Ian G. Campbell; Gareth Beynon; Michael Davis; Pat Englefield 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 735 KB

The CDKNZ gene encodes a cell cycle regulatory protein and is located on chromosome 9 ~2 1 , a region deleted in a wide variety of primary tumours. While mutations in the CDKNZ gene itself are frequently observed in tumour cell lines, they are less common in primary turnouts. We have investigated th

A low frequency of non-founder BRCA1 mut

A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast–ovarian cancer families

✍ Catherine M. Phelan; Elaine Kwan; Elaine Jack; Song Li; Cindy Morgan; Jennifer A 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

The 185delAG and 5382insC founder mutations account for the majority of mutations identified in BRCA1 in Ashkenazi Jewish breast and breast-ovarian cancer families. Few non-founder BRCA1 mutations have been identified to date in these families. We initially screened a panel of 245 Ashkenazi Jewish b

Human F-box protein hCdc4 targets cyclin

Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line

✍ Strohmaier, Heimo; Spruck, Charles H.; Kaiser, Peter; Won, Kwang-Ai; Sangfelt, O 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 486 KB

Frequency of TERT promoter mutations in

Frequency of TERT promoter mutations in human cancers

✍ Vinagre, João; Almeida, Ana; Pópulo, Helena; Batista, Rui; Lyra, Joana; Pinto, V 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 415 KB

Low frequency of BRAF and CDKN2A mutatio

Low frequency of BRAF and CDKN2A mutations in endometrial cancer

✍ Helga B. Salvesen; Rajiv Kumar; Ingunn Stefansson; Sabrina Angelini; Nicola MacD 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 196 KB 👁 1 views

## Abstract Several pathways have been implicated in the pathogenesis of endometrial carcinoma. Based on recent reports, __BRAF__ mutations provide an alternative route for activation of the RAS signalling pathway. The __CDKN2A (p16)__ tumour suppressor gene is also altered in several tumour types.